Guide for patients & caregivers
Significant Bronchodilator Response on Spirometry: What Does It Mean?
A significant bronchodilator response on spirometry explained: what the percentage means, old and new criteria, asthma vs COPD, and questions for your doctor.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a significant bronchodilator response on spirometry mean?
A significant bronchodilator response means that your lungs moved air out noticeably better after you inhaled a medicine that opens the airways. The improvement was large enough to pass a threshold set by lung-function standards, which suggests that at least part of the airway narrowing can be reversed. It supports a picture such as asthma, but it does not diagnose any condition by itself.
This guide is for adults reading a spirometry report that mentions bronchodilator response, reversibility or post-bronchodilator results. It focuses on what the percentage means. The basic numbers, such as FEV1, FVC and the FEV1/FVC ratio, are explained in our separate guide on an obstructive pattern on spirometry, so they are only summarised here.
Breathing symptoms that need urgent care
A test result is never a reason to wait if your breathing gets worse. The NHS advises calling emergency services or going to an emergency department if you have severe difficulty breathing, such as gasping, choking or being unable to get words out. Do not drive yourself.
If you have asthma and an attack is not improving, or you get worse at any time, the NHS says to call emergency services. Follow your own asthma action plan for using your reliever inhaler while you wait.
- Chest that feels tight or heavy, or pain spreading to the arms, back, neck or jaw.
- Lips or skin turning very pale, blue or grey.
- Sudden confusion.
- Get advice the same day if you are more short of breath than usual, are coughing up blood, or have pain or swelling in one leg.
How is a bronchodilator response test done?
Spirometry measures how much air you can blow out and how fast. The NHLBI describes a bronchodilator responsiveness test as comparing your spirometry before and after you inhale a fast-acting bronchodilator. The NHS explains that you may be asked to use an inhaler and repeat the test after a short break, to see whether the inhaler changes your result.
Because your usual inhalers could already be opening your airways, Cleveland Clinic says you may be asked to stop breathing medicines for a short period beforehand. The NHS says you will be told if you need to stop any medicines or inhalers, and advises not smoking for 24 hours before the test. Follow the instructions from your own testing service, and do not stop or change a prescribed inhaler or other medicine without talking to the prescriber.
What does the percentage on the report mean?
The report usually shows FEV1 (the air you blow out in the first second) and FVC (the total air you blow out) before and after the inhaler, with the change between them. That change can be expressed in different ways, which is why the percentage can be confusing.
An older rule, described in a review in the Ulster Medical Journal, counts a positive response in adults as FEV1 rising by at least 12% from your starting value and by at least 200 mL. A 2022 study in the International Journal of COPD explains that the 2005 European and American standard applied this 12% and 200 mL rule to FEV1 or FVC, while the 2021 update changed it to a rise of more than 10% of the value predicted for someone of your age, height and sex.
These two methods do not always agree. The same study found that fewer people with asthma or COPD counted as responders under the newer rule. So a result described as borderline under one method may read differently under another, and the percentage on your report only makes sense once you know which method was used.
Does a positive bronchodilator response mean asthma rather than COPD?
Not on its own. Reversible airway narrowing is described as the diagnostic hallmark of asthma in the Ulster Medical Journal review, and a positive response supports that picture. But COPD can also show a response. In the 2022 study of more than 12,000 patients, about 31% of people with COPD were responders under the older rule and about 23% under the newer rule, compared with about 63% and 53% of people with asthma. The authors concluded that it is hard to tell asthma from COPD on this test alone.
What happens after the inhaler also matters. Cleveland Clinic describes COPD as lung damage that is permanent. If the FEV1/FVC ratio stays low even after the bronchodilator, clinicians call the narrowing persistent, which is one feature they weigh when considering COPD. Some people improve with the inhaler and still have a low ratio afterwards, so improvement and persistent narrowing can appear on the same report. Clinicians read this together with smoking, work exposures, age, symptoms and sometimes imaging.
What if there was no significant response?
A negative result does not rule out asthma. Asthma can come and go, and the Ulster Medical Journal review notes that people with well-controlled asthma may have normal spirometry between flare-ups. It also says a negative test does not mean a person will get no benefit from bronchodilator treatment, and it advises combining the result with the history, examination and home peak flow records.
The NHLBI lists other tests that may help when asthma is still being considered. These include peak flow monitoring over time, challenge tests that check how sensitive the airways are, FeNO breath tests for airway inflammation, allergy tests and blood tests. Which of these makes sense depends on your symptoms and what question is still open.
Questions to ask your clinician
Bring the full report, including the before and after values, rather than a portal summary. Useful questions include:
- Which rule did my report use: 12% and 200 mL from my starting value, or more than 10% of my predicted value?
- Did my FEV1, my FVC or both improve after the inhaler?
- Was my FEV1/FVC ratio still low after the bronchodilator?
- Was I using any inhalers before the test that could have affected the result?
- Were my blows judged reliable and repeatable?
- What does this result add to my symptoms and history, and what other tests, if any, would help?
- When should spirometry be repeated, and which symptoms mean I should come back sooner?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Reading how others described their before-and-after results, the rule their report used and the tests that followed can help you see which questions are worth taking to your appointment.
Other people's results cannot be read as yours, and similar numbers can mean different things in different people. We suggest using shared cases only to prepare questions; your own clinician should guide any decision about diagnosis or treatment.
Sources and further reading
- NHLBI: Asthma diagnosis (bronchodilator responsiveness and other tests)
- NHS: Spirometry
- Cleveland Clinic: Spirometry
- Cleveland Clinic: Chronic obstructive pulmonary disease (COPD)
- Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011 (PMC)
- Li Y et al. Bronchodilator responsiveness defined by the 2005 and 2021 ERS/ATS criteria in asthma and COPD. Int J Chron Obstruct Pulmon Dis. 2022 (PMC, CC BY-NC)
- NHS: Chronic obstructive pulmonary disease (COPD) – urgent and emergency advice
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.